Observational Study of the Use of Pegloticase (KRYSTEXXA®) in Refractory Chronic Gout
Clinical trial NCT01466166 · COMPLETED
Trial details
- NCT number
- NCT01466166
- Sponsor
- Horizon Pharma Rheumatology LLC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-11-15
- Primary completion
- 2017-06-30
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.